The Cymerus brand, founded in 2013 (Australia), from 1 sister brand and 2214 competing brands. Cymerus is owned by CYNATA THERAPEUTIC NPV, listed on the stock exchange of Francfort The International Securities Identification Number (ISIN) of CYNATA THERAPEUTIC NPV is AU000000CYP7. Cymerus is part of the Biotechnology activity sector.

Cymerus is a brand of CYNATA THERAPEUTIC NPV (51S) Share price

International deposit : 2013 Business sector Biotechnology

Share price and profitability of the share CYNATA THERAPEUTIC NPV (Cymerus)

Buy CYNATA THERAPEUTIC NPV share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 0.10

Portfolio valuation
CYNATA THERAPEUTIC NPV (Cymerus) over 5 years* EUR 0.01

Stock market history CYNATA THERAPEUTIC NPV (Cymerus)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
CYNATA THERAPEUTIC NPV

CYNATA THERAPEUTIC NPV
CYNATA THERAPEUTIC NPV
See more brands of CYNATA THERAPEUTIC NPV

Rival brands
Cymerus

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS